Total Payments
$2,506
2024 Payments
$568.98
Companies
15
Transactions
181
Medicare Patients
3,164
Medicare Billing
$91,967
Payment Breakdown by Category
Food & Beverage$2,506 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,506 | 181 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $617.68 | 56 | $0 (2024) |
| Novo Nordisk Inc | $593.25 | 42 | $0 (2024) |
| Lilly USA, LLC | $342.76 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $323.08 | 21 | $0 (2024) |
| Abbott Laboratories | $198.50 | 9 | $0 (2024) |
| Genentech USA, Inc. | $110.77 | 17 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $65.86 | 3 | $0 (2023) |
| Medtronic, Inc. | $48.97 | 1 | $0 (2024) |
| Amarin Pharma Inc. | $46.11 | 3 | $0 (2021) |
| PFIZER INC. | $44.88 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $568.98 | 32 | Novo Nordisk Inc ($208.85) |
| 2023 | $641.32 | 41 | ABBVIE INC. ($187.15) |
| 2022 | $519.77 | 41 | ABBVIE INC. ($143.33) |
| 2021 | $775.48 | 67 | Novo Nordisk Inc ($177.51) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $48.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Obesity | ||||||
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: WOMENS HEALTH | ||||||
| 04/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes Care | ||||||
| 04/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 739 | 1,497 | $57,567 | $23,249 |
| 2022 | 13 | 731 | 1,374 | $44,338 | $19,587 |
| 2021 | 16 | 855 | 1,497 | $52,243 | $25,988 |
| 2020 | 14 | 839 | 1,571 | $53,141 | $23,144 |
Total Patients
3,164
Total Services
5,939
Medicare Billing
$91,967
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 234 | $25,780 | $10,335 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $8,037 | $5,170 | 64.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 56 | $4,200 | $1,607 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $3,174 | $1,374 | 43.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 109 | 193 | $5,597 | $1,350 | 24.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 33 | 34 | $2,550 | $1,343 | 52.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 88 | $704.00 | $682.08 | 96.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 17 | 34 | $595.00 | $551.48 | 92.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $2,280 | $539.40 | 23.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 40 | $400.00 | $136.40 | 34.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 91 | 116 | $2,320 | $75.58 | 3.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 31 | 160 | $800.00 | $52.06 | 6.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 91 | 452 | $1,130 | $32.71 | 2.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 192 | $18,380 | $8,833 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 43 | 43 | $6,450 | $4,475 | 69.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 66 | 73 | $5,475 | $2,076 | 37.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 34 | 36 | $2,700 | $1,464 | 54.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 103 | 162 | $4,698 | $1,194 | 25.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 19 | 40 | $700.00 | $651.08 | 93.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,173 | $318.57 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 78 | 99 | $632.00 | $291.64 | 46.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 30 | 35 | $350.00 | $120.26 | 34.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 83 | 96 | $1,920 | $78.66 | 4.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 24 | 112 | $560.00 | $35.56 | 6.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 96 | 460 | $1,150 | $34.88 | 3.0% |
About Blake Powers, PA-C
Blake Powers, PA-C is a Physician Assistant healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1023651007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Blake Powers, PA-C has received a total of $2,506 in payments from pharmaceutical and medical device companies, with $568.98 received in 2024. These payments were reported across 181 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,506).
As a Medicare-enrolled provider, Powers has provided services to 3,164 Medicare beneficiaries, totaling 5,939 services with total Medicare billing of $91,967. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Athens, TN
- Active Since 10/23/2019
- Last Updated 02/17/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1023651007
Products in Payments
- Ozempic (Drug) $383.95
- VRAYLAR (Drug) $327.37
- UBRELVY (Drug) $196.86
- BREZTRI (Drug) $141.55
- FREESTYLE LIBRE 2 (Device) $135.66
- Rybelsus (Drug) $132.89
- FARXIGA (Drug) $125.29
- TRULICITY (Drug) $122.14
- Xofluza (Drug) $110.77
- MOUNJARO (Drug) $96.53
- QULIPTA (Drug) $93.45
- EMGALITY (Drug) $80.80
- SEGLENTIS (Drug) $53.17
- INTELLIS ADAPTIVESTIM (Device) $48.97
- Vascepa (Drug) $46.11
- FREESTYLE LIBRE 3 (Device) $45.17
- PREMARIN (Drug) $44.88
- RYBELSUS (Drug) $44.39
- JARDIANCE (Drug) $43.29
- Descovy (Drug) $33.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Athens
Kirk Gautier, Pac, PAC
Physician Assistant — Payments: $301,906
Physician Assistant $301,906
Simon Bessette, Pa-C, PA-C
Physician Assistant — Payments: $21,534
Physician Assistant $21,534
Adriana Walsh, Pa-C, PA-C
Physician Assistant — Payments: $11,402
Physician Assistant $11,402
William Retterbush, Pa-C, PA-C
Physician Assistant — Payments: $7,302
Physician Assistant $7,302
Sebastian Afonso, Pac, PAC
Physician Assistant — Payments: $6,987
Physician Assistant $6,987
Ms. Miranda Seagraves, Pa-C, PA-C
Physician Assistant — Payments: $6,563
Physician Assistant $6,563